Nobody reads the cancellation clause on the way in — which is exactly what some subscription architectures count on. We pulled the exit terms across the GLP-1 telehealth market and scored them. The spread is wider than you'd guess: leaving some programs takes one click; others take a support ticket, a notice window, and a retention gauntlet.
Key Takeaways
- The four terms that define an exit: notice window, cancellation channel, commitment-plan exit rules, and refund policy on shipped product.
- Market range: same-day in-account cancellation with no notice window (best) to 7-day notice via support ticket only (worst).
- Commitment plans need a fifth term: the medical-exit policy — what happens if you can't medically continue.
- Rule of thumb: if you can't find the cancellation terms in five minutes before signing up, assume they're bad.
The Scoring Rubric
| Term | Good | Acceptable | Red flag |
|---|---|---|---|
| Notice window | None — effective immediately | 2–3 days before next charge | 5–7+ days |
| Channel | Self-serve button in account | Email with confirmed receipt | Support ticket or phone only |
| Commitment exit | Documented medical-exit policy | Pro-rated buyout | No exit until term ends |
| Refunds | Unshipped orders refundable | Case-by-case, responsive support | All sales final, silence |
What the Market Actually Looks Like
The good end: in-account cancellation, effective immediately, next charge simply doesn't happen, confirmation email arrives unprompted. This exists and is increasingly common — partly because strengthened U.S. click-to-cancel consumer protections have pushed subscription businesses toward symmetric signup/cancel flows.
The middle: a 2–5 day notice window before the billing date, cancellation via a short form or chat, one retention offer on the way out. Livable, if you calendar the window.
The lock-in end: ticket-only cancellation with response lag that conveniently spans the billing date; notice windows that turn a day-of decision into one more full charge; annual commitments with no written medical exit. Any two of those together is a provider telling you who they are.
The Commitment-Plan Question Nobody Asks
Annual pricing at $49–$99/month is genuinely good — but ask, in writing, before committing: "If my clinician discontinues me medically (pregnancy, adverse reaction, non-response), what happens to the remaining term?" The good answer is documented release or pro-rating. A shrug is a no, and a no should change your plan choice even if it doesn't change your provider.
Your Pre-Signup Five Minutes
- Search the help center for "cancel" — note window and channel.
- Find the refund policy for shipped vs. unshipped orders.
- Commitment plan? Get the medical-exit answer in writing.
- Screenshot all of it. Terms pages change; your screenshots don't.
Providers With Clean Exits in Our Tracking
Telos Rx — Semaglutide
Compounded semaglutide — from $49/mo on 12-month plans
Identical flat-at-every-dose structure on the semaglutide side.
Compounded medications are not FDA-approved.
Visit Telos Rx Paid linkEmbody
Injectable semaglutide — $149 first month
Our lead injectable pick: physician-supervised semaglutide with clean flat pricing after the intro month.
Compounded medications are not FDA-approved.
Visit Embody Paid linkWellorithm
Oral tablets — sema $147/mo, tirz $249/mo
Lowest published oral compounded pricing on our tracker.
Compounded medications are not FDA-approved.
Visit Wellorithm Paid linkVerdict: exit terms are the single best proxy for how a provider treats customers it isn't currently acquiring. Read the door before you walk through it.
Affiliate disclosure: Links marked "Paid link" are affiliate links. We may earn a commission if you sign up through them, at no extra cost to you. This supports our independent research.
Compounded medication notice: Compounded medications are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs before they are marketed. Brand-name alternatives (Wegovy, Ozempic, Zepbound, Rybelsus) are FDA-approved.
Medical disclaimer: This article is for informational purposes only and is not medical advice. GLP-1 medications are prescription drugs. Always consult a licensed healthcare provider about diagnosis, treatment, dosing, and whether these medications are appropriate for you.